Home » Author Archive

Image for Sycomore Asset Management Sells 32,253 Shares of Applied Materials, Inc. (NASDAQ:AMAT)

Sycomore Asset Management Sells 32,253 Shares of Applied Materials, Inc. (NASDAQ:AMAT)

Sycomore Asset Management decreased its position in Applied Materials, Inc. (NASDAQ:AMAT – Free Report) by 59.2% during the third quarter, HoldingsChannel.com reports. The firm owned 22,252 shares of the manufacturing equipment... More of this article »
Image for Invesco BulletShares 2027 Municipal Bond ETF (NASDAQ:BSMR) Short Interest Up 172.6% in October

Invesco BulletShares 2027 Municipal Bond ETF (NASDAQ:BSMR) Short Interest Up 172.6% in October

Invesco BulletShares 2027 Municipal Bond ETF (NASDAQ:BSMR – Get Free Report) saw a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 30,800 shares, an... More of this article »
Image for Intelligence Driven Advisers LLC Makes New Investment in Johnson & Johnson (NYSE:JNJ)

Intelligence Driven Advisers LLC Makes New Investment in Johnson & Johnson (NYSE:JNJ)

Intelligence Driven Advisers LLC bought a new position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) in the 3rd quarter, Holdings Channel reports. The fund bought 1,501 shares of the company’s stock, valued... More of this article »
Image for Bell Bank Sells 1,528 Shares of QUALCOMM Incorporated (NASDAQ:QCOM)

Bell Bank Sells 1,528 Shares of QUALCOMM Incorporated (NASDAQ:QCOM)

Bell Bank reduced its position in QUALCOMM Incorporated (NASDAQ:QCOM – Free Report) by 26.7% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 4,193 shares of the wireless technology company’s stock after... More of this article »
Image for Haverford Trust Co Grows Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Haverford Trust Co Grows Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Haverford Trust Co lifted its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 0.6% in the 3rd quarter, Holdings Channel.com reports. The firm owned 67,229 shares of the biopharmaceutical company’s stock... More of this article »